Seeing Is Believing

Currently out of the existing stock ratings of Erin Wright, 166 are a HOLD (31.09%), 312 are a BUY (58.43%), 56 are a SELL (10.49%).
Analyst Erin Wright, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 72.11% that have a potential upside of 17.5% achieved within 196 days.
Erin Wright’s has documented 1,111 price targets and ratings displayed on 3 stocks. The coverage is on Technology, Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on PETS, PetMed Express at 25-Sep-2026.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGS) at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Apr-2022
$12
$-0.19 (-1.56%)
$12
18 days ago
(15-Sep-2026)
14/20 (70%)
$-0.46 (-3.69%)
38
Hold Since 14-May-2025
$14
$2.38 (20.48%)
$39
1 months 21 days ago
(12-Aug-2026)
0/2 (0%)
$1.73 (14.10%)
Hold Since 12-Aug-2026
$15
$2.81 (23.05%)
$40
1 months 21 days ago
(12-Aug-2026)
3/4 (75%)
$2.73 (22.25%)
180
Sell Since 12-Feb-2026
$12
$-0.19 (-1.56%)
$6.5
1 months 22 days ago
(11-Aug-2026)
26/31 (83.87%)
$-1.38 (-10.31%)
99
Hold Since 09-Feb-2023
$12
$-0.19 (-1.56%)
$8
1 months 22 days ago
(11-Aug-2026)
21/28 (75%)
$-1.38 (-10.31%)
121
Which stock is Erin Wright most bullish on?
Which stock is Erin Wright most reserved on?
What Year was the first public recommendation made by Erin Wright?